Vencanna VenturesVENCF +80.00% PB Ratio is 0.09 as of Jun. 24, 2026, which is 73% below its 10-year median of 0.33. The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Vencanna Ventures ranks better than 95.77% on this metric.
The historical rank and industry rank for Vencanna Ventures's PB Ratio or its related term are showing as below:
VENCF'
s PB Ratio Range Over the Past 10 Years
Min: 0.12 Med: 0.33 Max: 0.59
Current: 0.33
During the past 13 years, Vencanna Ventures's highest PB Ratio was 0.59. The lowest was 0.12. And the median was 0.33.
VENCF's PB Ratio is ranked better than 95.77% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.88
vs VENCF: 0.33
During the past 12 months, Vencanna Ventures's average Book Value Per Share Growth Rate was -48.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -16.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -10.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 20.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vencanna Ventures was 122.40% per year. The lowest was -29.00% per year. And the median was -7.35% per year.
Back to Basics: PB Ratio
Vencanna Ventures (OTCPK:VENCF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Vencanna Ventures PB Ratio Related Terms
Vencanna Ventures PB Ratio Historical Data
* Premium members only.
The historical data trend for Vencanna Ventures's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vencanna Ventures PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's PB Ratio distribution charts can be found below:
* The bar in red indicates where Vencanna Ventures's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Vencanna Ventures (VENCF) has a PB Ratio of 0.09 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vencanna Ventures and its competitors. This is 73% below median its historical median of 0.33. Over the past decade, Vencanna Ventures' PB Ratio has ranged from 0.12 to 0.59. According to the industry distribution chart, Vencanna Ventures ranks #39 out of 922 companies in the Drug Manufacturers industry, placing it in the top 4.2%.
Is Vencanna Ventures' PB Ratio too high?
Vencanna Ventures' current PB Ratio of 0.09 is 73% below median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 0.59. The Drug Manufacturers industry median PB Ratio is 1.88. Vencanna Ventures' value of 0.09 is 95.2% below this industry median. Based on the distribution chart, Vencanna Ventures ranks #39 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Vencanna Ventures' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #39 out of 922 companies for PB Ratio. This places Vencanna Ventures in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.88. Vencanna Ventures' value of 0.09 is 95.2% below this benchmark. Historically, Vencanna Ventures' own PB Ratio has ranged from 0.12 to 0.59 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 1.88, Vencanna Ventures has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.88, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vencanna Ventures's current PB Ratio of 0.09 is 95.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current PB Ratio is 0.09, which is 73% below median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current PB Ratio of 0.09. The current PB Ratio is 0.09, which is 73% below median its 10-year median of 0.33 and 95.2% below the Drug Manufacturers industry median of 1.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current PB Ratio is 0.09 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VENCF has been successfully added to your 